Management of pharmaceutical substances in the environment: Lithuanian case study.

Investigation on the sources, discharges and related risks for the environment of the pharmaceutical substance (PhS) diclofenac (DCF) was performed in Lithuania, a country of the Baltic Sea region, for the first time. The investigation only refers to DCF as a PhS for human use; emissions from animal husbandry were not considered. In the first stage of the research, the main sources and pathways of DCF via substance flow analysis were identified within the country. During the second stage, DCF flows along the wastewater treatment plants (WWTPs) in two different cities were measured in order to assess the current levels of pharmaceutical residues in the environment. Furthermore, environmental risk assessment was carried out by taking into account the parameters of consumption data and elimination rate in WWTPs. Then, the assessment of different technical and managerial removal approaches was accomplished in an environmental management model of wastewater containing PhS, based on the framework of environmental systems theory.

[1]  Haidong Zhou,et al.  Removal of clofibric acid and diclofenac during anaerobic digestion of sewage sludge , 2013 .

[2]  Christoph Ort,et al.  Model-based evaluation of reduction strategies for micropollutants from wastewater treatment plants in complex river networks. , 2009, Environmental science & technology.

[3]  Robert Corrigan,et al.  Ireland and Incineration - A Very Long Engagement , 2011 .

[4]  Sylvain Coutu,et al.  Substance flow analysis as a tool for mitigating the impact of pharmaceuticals on the aquatic system. , 2013, Water research.

[5]  K. Kümmerer,et al.  Deactivation and transformation products in biodegradability testing of beta-lactams amoxicillin and piperacillin. , 2009, Chemosphere.

[6]  Loos Robert,et al.  Analytical methods relevant to the European Commission's 2012 proposal on Priority Substances under the Water Framework Directive , 2012 .

[7]  Chang-Ping Yu,et al.  Using material/substance flow analysis to support sustainable development assessment: A literature review and outlook , 2012 .

[8]  W. C. Li,et al.  Occurrence, sources, and fate of pharmaceuticals in aquatic environment and soil. , 2014, Environmental pollution.

[9]  A. Galarneau,et al.  Ion chromatography as highly suitable method for rapid and accurate determination of antibiotic fosfomycin in pharmaceutical wastewater. , 2014, Water science and technology : a journal of the International Association on Water Pollution Research.

[10]  D. Barceló,et al.  Occurrence, partition and removal of pharmaceuticals in sewage water and sludge during wastewater treatment. , 2011, Water research.

[11]  Jolanta Dvarionienė,et al.  Presence and Detection of Pharmaceutical Substances (Diclofenac, 17-β-estradiol, 17-α-etilinestradiol) in the Environment. Future Challenges for Lithuania , 2014 .

[12]  N Kreuzinger,et al.  Carbamazepine, diclofenac, ibuprofen and bezafibrate--investigations on the behaviour of selected pharmaceuticals during wastewater treatment. , 2004, Water science and technology : a journal of the International Association on Water Pollution Research.

[13]  N. Voulvoulis,et al.  Household Disposal of Pharmaceuticals as a Pathway for Aquatic Contamination in the United Kingdom , 2005, Environmental health perspectives.

[14]  H Kroiss,et al.  Removal of selected pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants. , 2005, Water research.

[15]  J. Santos,et al.  Occurrence of pharmaceutical compounds in wastewater and sludge from wastewater treatment plants: removal and ecotoxicological impact of wastewater discharges and sludge disposal. , 2012, Journal of hazardous materials.

[16]  A global assessment of chemical effluent dilution capacities from a macro-scale hydrological model , 2006 .

[17]  S. Geissen,et al.  Carbamazepine and diclofenac: removal in wastewater treatment plants and occurrence in water bodies. , 2008, Chemosphere.